Patients were randomized to receive 0.25 mL/kg/hr pyridoxalated hemoglobin polyoxyethylene ( 20 mg Hb/kg/hr ) or an equal volume of placebo , infused for up to 150 hours , in addition to conventional vasopressor therapy .